RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Ionis Pharmaceuticals Stock

Ionis Pharmaceuticals ROA 2024

Ionis Pharmaceuticals ROA

-0.12

Ticker

IONS

ISIN

US4622221004

WKN

A2ACMZ

In 2024, Ionis Pharmaceuticals's return on assets (ROA) was -0.12, a 15.09% increase from the -0.11 ROA in the previous year.

Ionis Pharmaceuticals Aktienanalyse

What does Ionis Pharmaceuticals do?

Ionis Pharmaceuticals is a biotechnology company specializing in the development and marketing of RNA-based therapeutics for the treatment of various diseases. The company was founded in 1989 and is headquartered in Carlsbad, California. Ionis Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Ionis Pharmaceuticals's Return on Assets (ROA)

Ionis Pharmaceuticals's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Ionis Pharmaceuticals's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Ionis Pharmaceuticals's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Ionis Pharmaceuticals’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Ionis Pharmaceuticals stock

What is the Return on Assets (ROA) of Ionis Pharmaceuticals this year?

The Return on Assets (ROA) of Ionis Pharmaceuticals is -0.12 undefined this year.

What was the ROA of Ionis Pharmaceuticals compared to the previous year?

The ROA of Ionis Pharmaceuticals has increased by 15.09% compared to the previous year.

What consequences do high ROA have for investors of Ionis Pharmaceuticals?

A high ROA is advantageous for investors of Ionis Pharmaceuticals, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Ionis Pharmaceuticals?

A low ROA can be unfavorable for investors of Ionis Pharmaceuticals as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Ionis Pharmaceuticals affect the company?

An increase in ROA of Ionis Pharmaceuticals can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Ionis Pharmaceuticals impact the company?

A reduction in the ROA of Ionis Pharmaceuticals can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Ionis Pharmaceuticals?

Some factors that can influence the ROA of Ionis Pharmaceuticals include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Ionis Pharmaceuticals important for investors?

The ROA of Ionis Pharmaceuticals is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Ionis Pharmaceuticals take to improve ROA?

To improve ROA, Ionis Pharmaceuticals can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Ionis Pharmaceuticals pay?

Over the past 12 months, Ionis Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Ionis Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Ionis Pharmaceuticals?

The current dividend yield of Ionis Pharmaceuticals is .

When does Ionis Pharmaceuticals pay dividends?

Ionis Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Ionis Pharmaceuticals?

Ionis Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Ionis Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Ionis Pharmaceuticals located?

Ionis Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Ionis Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Ionis Pharmaceuticals from 10/21/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/21/2024.

When did Ionis Pharmaceuticals pay the last dividend?

The last dividend was paid out on 10/21/2024.

What was the dividend of Ionis Pharmaceuticals in the year 2023?

In the year 2023, Ionis Pharmaceuticals distributed 0 USD as dividends.

In which currency does Ionis Pharmaceuticals pay out the dividend?

The dividends of Ionis Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Ionis Pharmaceuticals stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Ionis Pharmaceuticals

Our stock analysis for Ionis Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ionis Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.